1-2 of 2
Matthew Fawkes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Class Targeted Protein Degrader of MLLT1/3 for the Treatment of Advanced AML and ALL Including Menin Inhibitor Resistant / Refractory Disease

John Pollard, Graham Craggs, Gillian Farnie, Matthew Fawkes, Fenella Gross, Joe Harman, Marta Llorca-Cardenosa, Sarah Major, Alison Maloney, Thomas A Milne, Iain Simpson
Journal: Blood
Blood (2024) 144 (Supplement 1): 2772.
https://doi.org/10.1182/blood-2024-210052
Published: 2024
Journal Articles

Novel Inhibitors of MLLT1/3, a Critical Component of the Super-Elongation Complex (SEC), Target a Range of Molecularly Defined Acute Leukemias, with a Differential Profile to Menin Inhibition

John Pollard, Graham Craggs, Gillian Farnie, Matthew Fawkes, Oleg Fedorov, Charline Giroud, Fenella Gross, Joe Harman, Alison Maloney, Thomas Arthur Milne, Iain Simpson
Journal: Blood
Blood (2023) 142 (Supplement 1): 2789.
https://doi.org/10.1182/blood-2023-186638
Published: 2023